Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct 26;103(9):1462-6.
doi: 10.1038/sj.bjc.6605914. Epub 2010 Sep 28.

Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989

R H A Verhoeven  1 , W J Louwman, E L Koldewijn, T B J Demeyere, J W W Coebergh
Affiliations

Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989

R H A Verhoeven et al. Br J Cancer. .

Abstract

Background: Since the 1970s there have been few epidemiological studies of scrotal cancer. We report on the descriptive epidemiology of scrotal cancer in the Netherlands.

Methods: Data on all scrotal cancer patients were obtained from the Netherlands Cancer Registry (NCR) in the period 1989-2006 and age-standardised incidence rates were calculated also according to histology and stage. Relative survival was calculated and multiple primary tumours were studied.

Results: The overall incidence rate varied around 1.5 per 1,000,000 person-years, most frequently being squamous cell carcinoma (27%), basal cell carcinoma (19%) and Bowen's disease (15%). Overall 5-year relative survival was 82%, being 77% and 95% for patients with squamous and basal cell carcinoma, respectively. In all, 18% of the patients were diagnosed with a second primary tumour.

Conclusion: The incidence rate of scrotal cancer did not decrease, although this was expected; affected patients might benefit from regular checkups for possible new cancers.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Age distribution of patients diagnosed with scrotal cancer in the Netherlands according to histology (median, Q1, Q3, lowest and highest age).
Figure 2
Figure 2
Five-year moving-average European standardised scrotal cancer incidence rates per 1 000 000 person-years (mesotheliomas and lymphomas excluded).
Figure 3
Figure 3
European standardised scrotal cancer incidence rates per 1 000 000 person-years according to histology.
See this image and copyright information in PMC

References

    1. Andrews PE, Farrow GM, Oesterling JE (1991) Squamous cell carcinoma of the scrotum: long-term followup of 14 patients. J Urol 146: 1299–1304 - PubMed
    1. Coggon D, Inskip H, Winter P, Pannett B (1996) Mortality from scrotal cancer in metal machinists in England and Wales, 1979–80 and 1982–90. Occup Med (Lond) 46: 69–70 - PubMed
    1. de Vries E, van der Rhee H, Coebergh JW (2006) Trends, causes, approach and consequences related to the skin-cancer epidemic in the Netherlands and Europe. Ned Tijdschr Geneeskd 150: 1108–1115 - PubMed
    1. Doll R, Vessey MP, Beasley RWR, Buckley AR, Fear EC, Gammon EJ, Gunn W, Hughes GO, Lee K, Norman-Smith B (1972) Mortality of gasworkers: final report of a prospective study. Br J Ind Med 29: 394–406 - PMC - PubMed
    1. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (2000) International Classification of Diseases for Oncology. World Health Organization: Geneva